4//SEC Filing
Smith Michael David 4
Accession 0001209191-21-036596
CIK 0001348911other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 5:29 PM ET
Size
5.8 KB
Accession
0001209191-21-036596
Insider Transaction Report
Form 4
Smith Michael David
Sr. VP, Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-05-26+35,000→ 35,000 totalExercise: $25.95Exp: 2031-05-25→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests over a 4 year period: 1/48th on June 26, 2021, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001777800
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 5:29 PM ET
- Size
- 5.8 KB